We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology

Improving Sleep Quality through Cognitive Behavioural Therapy Alters Food Preferences in Adults with Overweight and Obesity

MedXY Editorial Team•Oct 5, 2025•Diabetes & Endocrinology
obesitysleep quality

Highlight

  • Cognitive behavioural therapy for insomnia (CBTi) significantly improves self-reported sleep duration and quality in overweight adults.
  • CBTi reduces cravings for sweet and savoury foods, improving food craving control and shifting implicit food preferences.
  • Objective accelerometer data showed no significant differences in sleep duration or efficiency, suggesting subjective improvements may precede measurable changes.
  • No clear evidence found yet for changes in actual dietary intake post-intervention, possibly due to under-reporting and limited sample size.

Study Background and Disease Burden

Short sleep duration and poor sleep quality have been consistently linked to increased caloric intake and a heightened preference for sweet, energy-dense foods. These factors contribute to the development and persistence of overweight and obesity, which are global public health concerns associated with increased morbidity and mortality risks, including cardiovascular disease, diabetes, and metabolic syndrome. Insomnia is a common comorbidity in individuals with overweight and obesity and may exacerbate eating behaviours that promote weight gain. Thus, interventions that improve sleep could potentially influence dietary behaviours and assist weight management strategies. Cognitive behavioural therapy for insomnia (CBTi) is an evidence-based approach recommended for improving sleep without medication, but its effects on food preferences and craving control have not been fully established.

Study Design

This randomized controlled trial enrolled 27 adults with overweight or obesity (BMI ≥ 25 kg/m²), short sleep duration ( 5). Participants were randomized to receive 8 weeks of CBTi (n=14) or serve as controls (n=13). Outcome measures included self-reported sleep duration and quality, daytime sleepiness (Epworth Sleepiness Scale), accelerometer-measured sleep parameters, three-day dietary food diaries, food craving assessments (Control of Eating Questionnaire), and explicit and implicit food preferences (Leeds Food Preference Questionnaire). Assessments were conducted before and after the intervention period.

Key Findings

The CBTi group self-reported a significantly greater increase in sleep duration (+1.11 ± 0.21 hours) compared to controls (+0.29 ± 0.30 hours; p=0.01). Sleep quality improved markedly in the CBTi group (PSQI reduction of -5.86 ± 0.73) versus controls (-0.62 ± 0.92; p=0.00002). Daytime sleepiness decreased significantly (-2.64 ± 0.80) with CBTi compared to an increase in the control group (+1.54 ± 0.66; p=0.00004). However, objective accelerometer data revealed no significant differences between groups in sleep duration or efficiency.

Importantly, the CBTi group demonstrated enhanced control over food cravings (+21.9 ± 4.7 mm) compared to controls who experienced a slight decline (-3.0 ± 4.3 mm; p=0.002). Cravings for sweet (-16.4 ± 6.0 mm vs +3.3 ± 4.2 mm; p=0.01) and savoury foods (-15.0 ± 3.0 mm vs +0.8 ± 4.8 mm; p=0.003) decreased more among CBTi participants. Implicit wanting for low-fat savoury foods increased (+12.3 ± 3.2) while that for high-fat sweet foods decreased (-15.8 ± 7.4) in the CBTi group versus respective changes in controls (-2.1 ± 3.1 and +9.8 ± 4.4; p=0.006 and p=0.001 respectively).

Regarding dietary intake, substantial under-reporting was evident with 19 participants reporting energy intakes below 1.1 times their basal metabolic rate. Among those who provided valid dietary data, no statistically significant differences were found between groups in changes to total energy intake or macronutrient composition, although limited statistical power due to small sample size must be acknowledged.

Expert Commentary

This trial provides compelling evidence that psychological interventions targeting sleep can positively influence food-related behaviours and preferences in adults with overweight and obesity. The observed subjective improvements in sleep and reductions in food cravings suggest a potential pathway through which improved sleep quality may contribute to healthier eating patterns. However, the lack of objective changes in sleep measured by accelerometer and absence of clear dietary intake modifications warrant cautious interpretation. Measurement challenges including under-reporting and the complexity of accurately assessing habitual dietary intake highlight ongoing methodological limitations in this field.

The neurobiological mechanisms underpinning these findings may involve improved regulation of appetite-related hormones (e.g., leptin, ghrelin) and altered reward processing circuits linked to food motivation following sleep restoration. Future studies incorporating biomarker analyses, larger sample sizes, and longer follow-up periods will be critical to determine the clinical significance of these behavioural changes and their impact on weight management outcomes.

Conclusion

Cognitive behavioural therapy for insomnia in overweight and obese adults enhances self-perceived sleep quality and duration, improves control over food cravings, and modifies implicit preferences toward healthier food options. While objective sleep improvements and clear dietary intake changes were not observed, the findings highlight CBTi as a promising adjunctive intervention for addressing modifiable behavioural risk factors associated with obesity. Further research is necessary to elucidate translation into long-term dietary behaviour modifications and weight loss.

References

Merchant AM, Gray SR, Gray CM, Finlayson G, Manyara AM, Gabler Trisotti MF, Gill JMR. Effect of a cognitive behavioural therapy intervention to improve sleep on food preferences: A randomized controlled trial in adults with overweight and obesity. Appetite. 2025 Aug 1;212:108022. doi: 10.1016/j.appet.2025.108022. Epub 2025 Apr 25. PMID: 40288612.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Oxytocin’s Role in Modulating Thyroid Function and Mental Health in Obesity: Insights from an 8-Week Clinical TrialAn 8-week trial reveals that intranasal oxytocin increases the free T3/free T4 ratio and correlates with improved mental health-related quality of life in adults with obesity, suggesting thyroid axis modulation as a potential mechanism forSep 17, 2026Obesity-Driven Left Atrial Remodeling in Atrial Fibrillation: Insights from Invasive Pressure-Volume AnalysisThis study reveals distinct left atrial structural and functional changes associated with obesity in atrial fibrillation patients, highlighting a load-related atrial remodeling that may underlie increased risks of atrial fibrillation and heSep 6, 2026Adult Overweight and Obesity Management: Key Updates from the 2025 VA/DoD Clinical Practice GuidelineA clear, clinician-focused summary of the 2025 VA/DoD guideline update: new screening thresholds, streamlined treatment pathways, integration of pharmacotherapy (including GLP‑1 receptor agonists), endoscopic and surgical options, and veterAug 27, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Exercise Reverses Obesity-Driven Immune Dysfunction in Lung Cancer: New Insights for Therapy and Prevention
Physical activity counteracts adiposity-induced immune suppression in lung cancer and non-tumor lungs, restoring antitumor immunity and slowing tumor progression, with implications for lung cancer interception.
Aug 25, 2026
Tailoring Misoprostol Dosing for Labor Induction: The Influence of BMI and Administration RouteObesity increases the number of misoprostol doses needed for active labor during induction, with buccal dosing requiring more doses than vaginal, highlighting implications for individualized labor management.Aug 25, 2026
Mazdutide: A Novel Dual Agonist Demonstrates Significant Weight Loss in Adults with Obesity or OverweightMazdutide, a once-weekly glucagon and GLP-1 receptor dual agonist, delivers clinically meaningful weight reduction in adults with obesity or overweight, with higher doses yielding superior outcomes and manageable safety profiles.Aug 22, 2026